SEC Form 4 · accession 0001156375-18-000133

CME GROUP INC. · CME

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Sr MD Chief Commercial Officer

Period of report

Nov 16, 2018

Accepted (ET)

Nov 20, 2018 · 1:19 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001156375

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock Class A	Nov 16, 2018	M	2,670	$54.30	A	24,255	D
Common Stock Class A^F1	Nov 16, 2018	S	2,670	$195.01	D	21,585	D
Common Stock Class A	Nov 16, 2018	M	1,310	$56.87	A	22,895	D
Common Stock Class A^F1	Nov 16, 2018	S	1,310	$195.01	D	21,585	D
Common Stock Class A^F1	Nov 16, 2018	S	1,867	$195.01	D	19,718	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F2	$54.30	Nov 16, 2018	M	2,670	D	Sep 15, 2014	Sep 15, 2020	Common Stock Class A	2,670	2,670	D
Non-Qualified Stock Option (right to buy)^F3	$56.87	Nov 16, 2018	M	1,310	D	Sep 13, 2013	Sep 15, 2019	Common Stock Class A	1,310	0	D

F1On November 16, 2018, Ms. Winkler sold an aggregate of 5,847 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $194.95 to $195.18. The Company maintains a record of the transactions and copies will be provided upon request.
F2As of 9/15/2014, this option vested with respect to 100% of the granted number of shares covered by the option.
F3As of 9/15/2013, this option vested with respect to 100% of the granted number of shares covered by the option.